{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T04:31:33Z","timestamp":1783485093971,"version":"3.55.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,11]]},"DOI":"10.7759\/cureus.54018","type":"journal-article","created":{"date-parts":[[2024,2,11]],"date-time":"2024-02-11T16:58:15Z","timestamp":1707670695000},"source":"Crossref","is-referenced-by-count":5,"title":["Advancements in Heart Transplantation: Donor-Derived Cell-Free DNA as Next-Generation Biomarker"],"prefix":"10.7759","author":[{"given":"Pawel","family":"Borkowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikita","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Borkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2021.01.022","article-title":"Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure","volume":"27","author":"Bozkurt B","year":"2021","unstructured":"Bozkurt B, Coats AJ, Tsutsui H, et al.. Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure. J Card Fail. 2021, 27:P387-413. 10.1016\/j.cardfail.2021.01.022","journal-title":"J Card Fail"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2015.04.235","article-title":"The patient perspective: quality of life in advanced heart failure with frequent hospitalisations","volume":"191","author":"Nieminen MS","year":"2015","unstructured":"Nieminen MS, Dickstein K, Fonseca C, et al.. The patient perspective: quality of life in advanced heart failure with frequent hospitalisations. Int J Cardiol. 2015, 191:256-64. 10.1016\/j.ijcard.2015.04.235","journal-title":"Int J Cardiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2021.12.012","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Heidenreich PA","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, et al.. 2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2022, 79:e263-421. 10.1016\/j.jacc.2021.12.012","journal-title":"J Am Coll Cardiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.052925","article-title":"Solid gold, or liquid gold? Towards a new diagnostic standard for heart transplant rejection","volume":"143","author":"Kittleson MM","year":"2021","unstructured":"Kittleson MM, Garg S. Solid gold, or liquid gold? Towards a new diagnostic standard for heart transplant rejection. Circulation. 2021, 143:1198-201. 10.1161\/CIRCULATIONAHA.120.052925","journal-title":"Circulation"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.16492","article-title":"OPTN\/SRTR 2019 Annual Data Report: Heart","volume":"21 Suppl 2","author":"Colvin M","year":"2021","unstructured":"Colvin M, Smith JM, Ahn Y, et al.. OPTN\/SRTR 2019 Annual Data Report: Heart. Am J Transplant. 2021, 21 Suppl 2:356-440. 10.1111\/ajt.16492","journal-title":"Am J Transplant"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajt.2023.02.008","article-title":"OPTN\/SRTR 2021 annual data report: heart","volume":"23","author":"Colvin MM","year":"2023","unstructured":"Colvin MM, Smith JM, Ahn YS, et al.. OPTN\/SRTR 2021 annual data report: heart. Am J Transplant. 2023, 23:S300-78. 10.1016\/j.ajt.2023.02.008","journal-title":"Am J Transplant"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.15686","article-title":"Association of transplant center with survival benefit among adults undergoing heart transplant in the United States","volume":"322","author":"Parker WF","year":"2019","unstructured":"Parker WF, Anderson AS, Gibbons RD, Garrity ER Jr, Ross LF, Huang ES, Churpek MM. Association of transplant center with survival benefit among adults undergoing heart transplant in the United States. JAMA. 2019, 322:1789-98. 10.1001\/jama.2019.15686","journal-title":"JAMA"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s00059-018-4745-8","article-title":"Health-related quality of life in adult heart-transplant recipients-a\u00a0systematic review","volume":"45","author":"Tackmann E","year":"2020","unstructured":"Tackmann E, Dettmer S. Health-related quality of life in adult heart-transplant recipients-a\u00a0systematic review. Herz. 2020, 45:475-82. 10.1007\/s00059-018-4745-8","journal-title":"Herz"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s11886-018-1018-3","article-title":"Complications of cardiac transplantation","volume":"20","author":"Potena L","year":"2018","unstructured":"Potena L, Zuckermann A, Barberini F, Aliabadi-Zuckermann A. Complications of cardiac transplantation. Curr Cardiol Rep. 2018, 20:73. 10.1007\/s11886-018-1018-3","journal-title":"Curr Cardiol Rep"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccc.2014.03.005","article-title":"Post-heart transplant complications","volume":"30","author":"Birati EY","year":"2014","unstructured":"Birati EY, Rame JE. Post-heart transplant complications. Crit Care Clin. 2014, 30:629-37. 10.1016\/j.ccc.2014.03.005","journal-title":"Crit Care Clin"},{"key":"ref11","article-title":"Endomyocardial biopsy for monitoring heart transplant patients: 11-years-experience at a German heart center","volume":"6","author":"Strecker T","year":"2013","unstructured":"Strecker T, R\u00f6sch J, Weyand M, Agaimy A. Endomyocardial biopsy for monitoring heart transplant patients: 11-years-experience at a German heart center. Int J Clin Exp Pathol. 2013, 6:55-65.","journal-title":"Int J Clin Exp Pathol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-97-6-885","article-title":"Endomyocardial biopsy","volume":"97","author":"Fowles RE","year":"1982","unstructured":"Fowles RE, Mason JW. Endomyocardial biopsy. Ann Intern Med. 1982, 97:885-94. 10.7326\/0003-4819-97-6-885","journal-title":"Ann Intern Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2011.03.010","article-title":"Complications of endomyocardial biopsy in heart transplant patients: a retrospective study of 2117 consecutive procedures","volume":"43","author":"Saraiva F","year":"2011","unstructured":"Saraiva F, Matos V, Gon\u00e7alves L, Antunes M, Provid\u00eancia LA. Complications of endomyocardial biopsy in heart transplant patients: a retrospective study of 2117 consecutive procedures. Transplant Proc. 2011, 43:1908-12. 10.1016\/j.transproceed.2011.03.010","journal-title":"Transplant Proc"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2021.05.008","article-title":"Diagnostic accuracy of cardiovascular magnetic resonance for cardiac transplant rejection: a meta-analysis","volume":"14","author":"Han D","year":"2021","unstructured":"Han D, Miller RJ, Otaki Y, et al.. Diagnostic accuracy of cardiovascular magnetic resonance for cardiac transplant rejection: a meta-analysis. JACC Cardiovasc Imaging. 2021, 14:2337-49. 10.1016\/j.jcmg.2021.05.008","journal-title":"JACC Cardiovasc Imaging"},{"key":"ref15","article-title":"Nuclear acids in human blood plasma [Article in French]","volume":"142","author":"Mandel P","year":"1948","unstructured":"Mandel P, Metais P. Nuclear acids in human blood plasma [Article in French]. C R Seances Soc Biol Fil. 1948, 142:241-3.","journal-title":"C R Seances Soc Biol Fil"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-74288-2","article-title":"Cell-free DNA in plasma as an essential immune system regulator","volume":"10","author":"Korabecna M","year":"2020","unstructured":"Korabecna M, Zinkova A, Brynychova I, et al.. Cell-free DNA in plasma as an essential immune system regulator. Sci Rep. 2020, 10:17478. 10.1038\/s41598-020-74288-2","journal-title":"Sci Rep"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.2147\/IJWH.S67124","article-title":"Non-invasive prenatal testing: a review of international implementation and challenges","volume":"7","author":"Allyse M","year":"2015","unstructured":"Allyse M, Minear MA, Berson E, Sridhar S, Rote M, Hung A, Chandrasekharan S. Non-invasive prenatal testing: a review of international implementation and challenges. Int J Womens Health. 2015, 7:113-26. 10.2147\/IJWH.S67124","journal-title":"Int J Womens Health"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00502","article-title":"Cell-free DNA as a biomarker in autoimmune rheumatic diseases","volume":"10","author":"Duvvuri B","year":"2019","unstructured":"Duvvuri B, Lood C. Cell-free DNA as a biomarker in autoimmune rheumatic diseases. Front Immunol. 2019, 10:502. 10.3389\/fimmu.2019.00502","journal-title":"Front Immunol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-021-01696-0","article-title":"Cell-free DNA analysis in current cancer clinical trials: a review","volume":"126","author":"Cisneros-Villanueva M","year":"2022","unstructured":"Cisneros-Villanueva M, Hidalgo-P\u00e9rez L, Rios-Romero M, et al.. Cell-free DNA analysis in current cancer clinical trials: a review. Br J Cancer. 2022, 126:391-400. 10.1038\/s41416-021-01696-0","journal-title":"Br J Cancer"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.049098","article-title":"Cell-free DNA to detect heart allograft acute rejection","volume":"143","author":"Agbor-Enoh S","year":"2021","unstructured":"Agbor-Enoh S, Shah P, Tunc I, et al.. Cell-free DNA to detect heart allograft acute rejection. Circulation. 2021, 143:1184-97. 10.1161\/CIRCULATIONAHA.120.049098","journal-title":"Circulation"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.2217\/bmm-2021-0968","article-title":"Cell-free DNA as a solid-organ transplant biomarker: technologies and approaches","volume":"16","author":"Edwards RL","year":"2022","unstructured":"Edwards RL, Menteer J, Lestz RM, Baxter-Lowe LA. Cell-free DNA as a solid-organ transplant biomarker: technologies and approaches. Biomark Med. 2022, 16:401-15. 10.2217\/bmm-2021-0968","journal-title":"Biomark Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1770-3","article-title":"Cell-free DNA analysis in healthy individuals by next-generation sequencing: a proof of concept and technical validation study","volume":"10","author":"Alborelli I","year":"2019","unstructured":"Alborelli I, Generali D, Jermann P, et al.. Cell-free DNA analysis in healthy individuals by next-generation sequencing: a proof of concept and technical validation study. Cell Death Dis. 2019, 10:534. 10.1038\/s41419-019-1770-3","journal-title":"Cell Death Dis"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-69432-x","article-title":"Evaluating the quantity, quality and size distribution of cell-free DNA by multiplex droplet digital PCR","volume":"10","author":"Alcaide M","year":"2020","unstructured":"Alcaide M, Cheung M, Hillman J, et al.. Evaluating the quantity, quality and size distribution of cell-free DNA by multiplex droplet digital PCR. Sci Rep. 2020, 10:12564. 10.1038\/s41598-020-69432-x","journal-title":"Sci Rep"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2023.08.016","article-title":"Cost and use trends of endomyocardial biopsy in heart transplant patients: a 4-year claims data analysis","volume":"55","author":"Vilalta A","year":"2023","unstructured":"Vilalta A. Cost and use trends of endomyocardial biopsy in heart transplant patients: a 4-year claims data analysis. Transplant Proc. 2023, 55:2186-90. 10.1016\/j.transproceed.2023.08.016","journal-title":"Transplant Proc"},{"key":"ref25","unstructured":"U.S. Securities and Exchange Commission. Washington, D.C. 20549. Form 10-K. https.\/\/www.sec.gov\/Archives\/edgar\/data\/1217234\/000156459018006584\/cdna-10k_20171231.htm."},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3390\/cimb44060184","article-title":"Current and future perspectives of cell-free DNA in liquid biopsy","volume":"44","author":"Liu S","year":"2022","unstructured":"Liu S, Wang J. Current and future perspectives of cell-free DNA in liquid biopsy. Curr Issues Mol Biol. 2022, 44:2695-709. 10.3390\/cimb44060184","journal-title":"Curr Issues Mol Biol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.1031894","article-title":"Donor-derived cell-free DNA as a diagnostic tool in transplantation","volume":"13","author":"Oellerich M","year":"2022","unstructured":"Oellerich M, Budde K, Osmanodja B, Bornemann-Kolatzki K, Beck J, Sch\u00fctz E, Walson PD. Donor-derived cell-free DNA as a diagnostic tool in transplantation. Front Genet. 2022, 13:1031894. 10.3389\/fgene.2022.1031894","journal-title":"Front Genet"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.tpr.2021.100079","article-title":"Single center experience comparing two clinically available donor derived cell free DNA tests and review of literature","volume":"6","author":"Lum EL","year":"2021","unstructured":"Lum EL, Nieves-Borrero K, Homkrailas P, Lee S, Danovitch G, Bunnapradist S. Single center experience comparing two clinically available donor derived cell free DNA tests and review of literature. Transplant Rep. 2021, 6:100079. 10.1016\/j.tpr.2021.100079","journal-title":"Transplant Rep"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000003725","article-title":"Graft-derived cell-free DNA as a noninvasive biomarker of cardiac allograft rejection: a cohort study on clinical validity and confounding factors","volume":"106","author":"Kn\u00fcttgen F","year":"2022","unstructured":"Kn\u00fcttgen F, Beck J, Dittrich M, et al.. Graft-derived cell-free DNA as a noninvasive biomarker of cardiac allograft rejection: a cohort study on clinical validity and confounding factors. Transplantation. 2022, 106:615-22. 10.1097\/TP.0000000000003725","journal-title":"Transplantation"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.10069","article-title":"Circulating cell-free DNA as a prognostic and predictive biomarker in non-small cell lung cancer","volume":"7","author":"Ai B","year":"2016","unstructured":"Ai B, Liu H, Huang Y, Peng P. Circulating cell-free DNA as a prognostic and predictive biomarker in non-small cell lung cancer. Oncotarget. 2016, 7:44583-95. 10.18632\/oncotarget.10069","journal-title":"Oncotarget"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1097\/TXD.0000000000001027","article-title":"Graft-derived cell-free DNA as a noninvasive biomarker of cardiac allograft rejection: a cohort study on clinical validity and confounding factors","volume":"6","author":"Huang E","year":"2020","unstructured":"Huang E, Gillespie M, Ammerman N, et al.. Graft-derived cell-free DNA as a noninvasive biomarker of cardiac allograft rejection: a cohort study on clinical validity and confounding factors. Transplant Direct. 2020, 6:e580. 10.1097\/TXD.0000000000001027","journal-title":"Transplant Direct"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.15339","article-title":"Noninvasive detection of graft injury after heart transplant using donor-derived cell-free DNA: a prospective multicenter study","volume":"19","author":"Khush KK","year":"2019","unstructured":"Khush KK, Patel J, Pinney S, et al.. Noninvasive detection of graft injury after heart transplant using donor-derived cell-free DNA: a prospective multicenter study. Am J Transplant. 2019, 19:2889-99. 10.1111\/ajt.15339","journal-title":"Am J Transplant"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2022.11.002","article-title":"The end of endomyocardial biopsy?: a practical guide for noninvasive heart transplant rejection surveillance","volume":"11","author":"Holzhauser L","year":"2023","unstructured":"Holzhauser L, DeFilippis EM, Nikolova A, et al.. The end of endomyocardial biopsy?: a practical guide for noninvasive heart transplant rejection surveillance. JACC Heart Fail. 2023, 11:263-76. 10.1016\/j.jchf.2022.11.002","journal-title":"JACC Heart Fail"},{"key":"ref34","article-title":"Heart Transplantation Rejection","author":"Ludhwani D","year":"2024","unstructured":"Ludhwani D, Abraham J, Kanmanthareddy A. Heart Transplantation Rejection. StatPearls [Internet], Treasure Island (FL); 2024."},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000093","article-title":"Antibody-mediated rejection in cardiac transplantation: emerging knowledge in diagnosis and management: a scientific statement from the American Heart Association","volume":"131","author":"Colvin MM","year":"2015","unstructured":"Colvin MM, Cook JL, Chang P, et al.. Antibody-mediated rejection in cardiac transplantation: emerging knowledge in diagnosis and management: a scientific statement from the American Heart Association. Circulation. 2015, 131:1608-39. 10.1161\/CIR.0000000000000093","journal-title":"Circulation"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2022.06.019","article-title":"Circulating microRNAs in cellular and antibody-mediated heart transplant rejection","volume":"41","author":"Shah P","year":"2022","unstructured":"Shah P, Agbor-Enoh S, Bagchi P, et al.. Circulating microRNAs in cellular and antibody-mediated heart transplant rejection. J Heart Lung Transplant. 2022, 41:1401-13. 10.1016\/j.healun.2022.06.019","journal-title":"J Heart Lung Transplant"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13233540","article-title":"Donor-derived cell-free DNA as a non-invasive biomarker for graft rejection in kidney transplant recipients: a prospective study among the Indian population","volume":"13","author":"Kumar N","year":"2023","unstructured":"Kumar N, Tandon A, Rana R, et al.. Donor-derived cell-free DNA as a non-invasive biomarker for graft rejection in kidney transplant recipients: a prospective study among the Indian population. Diagnostics (Basel). 2023, 13:3540. 10.3390\/diagnostics13233540","journal-title":"Diagnostics (Basel)"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.17226\/12875","article-title":"Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care","year":"2003","unstructured":"Unequal Treatment. Confronting Racial and Ethnic Disparities in Health Care. Smedley BD, Stith AY, Nelson AR (ed): National Academies Press, Washington (DC); 2003. 10.17226\/12875"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.110.976811","article-title":"Persistent racial disparities in survival after heart transplantation","volume":"123","author":"Liu V","year":"2011","unstructured":"Liu V, Bhattacharya J, Weill D, Hlatky MA. Persistent racial disparities in survival after heart transplantation. Circulation. 2011, 123:1642-9. 10.1161\/CIRCULATIONAHA.110.976811","journal-title":"Circulation"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2021.12.006","article-title":"Higher levels of allograft injury in black patients early after heart transplantation","volume":"41","author":"Doshi A","year":"2022","unstructured":"Doshi A, Shah KB, Agbor-Enoh S, et al.. Higher levels of allograft injury in black patients early after heart transplantation. J Heart Lung Transplant. 2022, 41:855-8. 10.1016\/j.healun.2021.12.006","journal-title":"J Heart Lung Transplant"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1001\/jama.293.14.1783","article-title":"Confronting genetic testing disparities: knowledge is power","volume":"293","author":"Hall M","year":"2005","unstructured":"Hall M, Olopade OI. Confronting genetic testing disparities: knowledge is power. JAMA. 2005, 293:1783-5. 10.1001\/jama.293.14.1783","journal-title":"JAMA"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1093\/jlb\/lsz007","article-title":"The law of genetic privacy: applications, implications, and limitations","volume":"6","author":"Clayton EW","year":"2019","unstructured":"Clayton EW, Evans BJ, Hazel JW, Rothstein MA. The law of genetic privacy: applications, implications, and limitations. J Law Biosci. 2019, 6:1-36. 10.1093\/jlb\/lsz007","journal-title":"J Law Biosci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/228012-advancements-in-heart-transplantation-donor-derived-cell-free-dna-as-next-generation-biomarker","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,11]],"date-time":"2024-02-11T16:58:20Z","timestamp":1707670700000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/228012-advancements-in-heart-transplantation-donor-derived-cell-free-dna-as-next-generation-biomarker"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,11]]},"references-count":42,"URL":"https:\/\/doi.org\/10.7759\/cureus.54018","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2,11]]}}}